Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1991 Oct;29(10):2329–2330. doi: 10.1128/jcm.29.10.2329-2330.1991

Evaluation of first- and second-generation RIBA kits for detection of antibody to hepatitis C virus.

R K Chaudhary 1, C MacLean 1
PMCID: PMC270322  PMID: 1719025

Abstract

Samples reactive by first-generation recombinant immunoblot assay (RIBA) to detect antibody to hepatitis C virus (anti-HCV) (RIBA-1 [Chiron, Calif.]) remained reactive by a second-generation test (RIBA-2) for HCV antibodies. A total of 75% of specimens indeterminate by RIBA-1 became reactive, 12.5% were nonreactive, and 12.5% remained indeterminate by RIBA-2. Among RIBA-1-nonreactive specimens, 12.0% became positive and 5.1% became indeterminate by RIBA-2. The antigens c33c and c22-3 have increased the sensitivity of RIBA-2.

Full text

PDF
2329

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter M. J., Gerety R. J., Smallwood L. A., Sampliner R. E., Tabor E., Deinhardt F., Frösner G., Matanoski G. M. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis. 1982 Jun;145(6):886–893. doi: 10.1093/infdis/145.6.886. [DOI] [PubMed] [Google Scholar]
  2. Bellobuono A., Mozzi F., Petrini G., Zanella A., Sirchia G. Infectivity of blood that is immunoblot intermediate reactive on hepatitis C virus antibody testing. Lancet. 1990 Aug 4;336(8710):309–309. doi: 10.1016/0140-6736(90)91840-7. [DOI] [PubMed] [Google Scholar]
  3. Ebeling F., Naukkarinen R., Leikola J. Recombinant immunoblot assay for hepatitis C virus antibody as predictor of infectivity. Lancet. 1990 Apr 21;335(8695):982–983. doi: 10.1016/0140-6736(90)91055-f. [DOI] [PubMed] [Google Scholar]
  4. Fletcher M. L., Trowell J. M., Craske J., Pavier K., Rizza C. R. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J (Clin Res Ed) 1983 Dec 10;287(6407):1754–1757. doi: 10.1136/bmj.287.6407.1754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Galbraith R. M., Eddleston A. L., Portmann B., Williams R., Gower P. E. Chronic liver disease developing after outbreak of HBsAG-negative hepatitis in haemodialysis unit. Lancet. 1975 Nov 8;2(7941):886–890. doi: 10.1016/s0140-6736(75)92126-1. [DOI] [PubMed] [Google Scholar]
  6. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  7. Mosley J. W., Redeker A. G., Feinstone S. M., Purcell R. H. Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med. 1977 Jan 13;296(2):75–78. doi: 10.1056/NEJM197701132960204. [DOI] [PubMed] [Google Scholar]
  8. Van der Poel C. L., Cuypers H. T., Reesink H. W., Weiner A. J., Quan S., Di Nello R., Van Boven J. J., Winkel I., Mulder-Folkerts D., Exel-Oehlers P. J. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet. 1991 Feb 9;337(8737):317–319. doi: 10.1016/0140-6736(91)90942-i. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES